发明名称 |
PHARMACEUTICAL COMPOSITIONS OF THE ISOLATED D-ENANTIOMER OF THE QUINAZOLINONE DERIVATIVE HALOFUGINONE |
摘要 |
The present invention relates to pharmaceutical compositions comprising as an active ingredient an isolated, chirally pure D-enantiomer of the quinazolinone derivative halofuginone having increased therapeutic activity and decreased side effects compared to the corresponding racemic mixtures, the composition being substantially free of the L-enantiomer and useful in the treatment of diseases and disorders associated with fibrotic conditions or cell proliferation.
|
申请公布号 |
US2011212165(A1) |
申请公布日期 |
2011.09.01 |
申请号 |
US201113102730 |
申请日期 |
2011.05.06 |
申请人 |
EREZ MORDECHAI;HALEVI KARIN |
发明人 |
EREZ MORDECHAI;HALEVI KARIN |
分类号 |
A61K9/127;A61K31/517;A61P1/16;A61P9/10;A61P17/06;A61P17/08;A61P17/10;A61P17/14;A61P35/00;A61P37/06;C07D401/06 |
主分类号 |
A61K9/127 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|